Cetraxate
Top View
- Nasally Administrable Compositions Containing Physiologically Active Peptides
- United States Patent (19) 11 Patent Number: 5,908,824 Yanagawa (45) Date of Patent: Jun
- (12) Patent Application Publication (10) Pub. No.: US 2005/0089577 A1 Yokoyama Et Al
- United States Patent (19) 11) Patent Number: 5,620,964 Roth Et Al
- Lopresti, Michael1 1Department of Health Economics and Outcomes Research, Graduate School of Pharmaceutical Sciences, the University of Tokyo, Tokyo, Japan
- Lack of Influence of Substrate on Ligand Interaction with the Human Multidrug and Toxin Extruder, MATE1 S
- ICD-10-CM TABLE of DRUGS and CHEMICALS 2020
- The Influence of Pretreatment on Cure Rates of Helicobacter Pylori Eradication
- Oral Preparation
- Helicobacter Pylori Infection and Gastric Cancer
- (19) United States (12) Patent Application Publication (10) Pub
- Efficacy of a Quadruple Therapy Regimen for Helicobacter Pylori
- Prevention of NSAID-Associated Gastroduodenal Injury in Healthy Volunteers-A Randomized, Double-Blind, Multicenter Study Comparing DA-9601 with Misoprostol
- Nig. J. Physiol. Sci. 26(June 2011) 049 – 054 Nig
- European Patent Office
- 1716 Gastrointestinal Drugs
- Polymer-Combined Drug and a Method for Producing the Drug
- INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri